1. Systematic review for the serological testing for cold agglutinins: The BEST collaborative study.
- Author
-
Jalink, Marit, Yan, Matthew T. S., Cohn, Claudia S., Eichbaum, Quentin G., Fung, Mark K., Lu, Wen, Murphy, Michael F., Pagano, Monica B., Stanworth, Simon J., and Shih, Andrew W.
- Subjects
- *
AUTOIMMUNE hemolytic anemia , *SERODIAGNOSIS , *SARS-CoV-2 , *AGGLUTININS - Abstract
This document is a systematic review that discusses the challenges and inconsistencies in diagnosing cold agglutinins (CA), which are IgM autoantibodies that can cause hemolysis. The review aims to inform future research on the diagnostic investigation and interpretation of CA by describing serological techniques and cut-offs for diagnosing cold agglutinin disease (CAD) or cold agglutinin syndrome (CAS). The authors conducted a literature search and included 56 articles in their analysis, which revealed a lack of standardized definitions and thresholds for diagnosing clinically significant CA. The document provides a summary of various studies and case series related to cold agglutinins (CA), examining different aspects such as the number of participants with CA, the underlying clinical diseases studied, and the definition of CA. It presents a range of perspectives and findings from different studies. The article discusses the lack of consistency in defining the characteristics of cold agglutinin disease (CAD) in autoimmune hemolytic anemia (AIHA). The most commonly used laboratory test for diagnosing CAD is the direct antiglobulin test (DAT), which detects complement deposition on red blood cells. However, the clinical utility of DAT testing and the interpretation of results are variable. CA titers, which reflect the concentration and avidity of cold agglutinins, are also widely used but do not always correlate with disease severity. The determination of thermal amplitude [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF